Donate

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Brentuximab vedotin

Brentuximab vedotin (April 2020)

Brentuximab vedotin is a targeted drug used in the treatment of certain types of lymphoma. This factsheets explains what it is, who can have it, how it is given, the benefits and possible side effects.

Author(s)
Lymphoma Action
Place of publication
Aylesbury
Publisher
Lymphoma Action
Date of publication
April 2020
Pages
7pp
Supplier
https://lymphoma-action.org.uk/
Subject(s)
Lymphomas, Biological therapies, Monoclonal antibodies, Brentuximab vedotin, Adcetris®
Format
Factsheet
Language
English
Flesch readability score
47.7
Download this resource
Download this resource
Back to results
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Donate

About this site

Macmillan sites

Right there with you

We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you. Contact us

Follow us

© Macmillan Cancer Support 2019 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007